Rinat Neuroscience Corp. develops and commercializes protein-based therapeutics for the treatment of diseases and disorders of the nervous system. The company develops neuroscience-based protein therapeutics for pain, Alzheimer’s disease, obesity and diabetes, and neuropathies. Rinat Neuroscience Corp. also develops disease modifying therapies that modulate the function, as well as prevent and reverse the damage to key populations of neurons specifically affected in particular disease states. The company was incorporated in 2000 and is based in South San Francisco, California. As of May 16, 2006, Rinat Neuroscience Corp. operates as a subsidiary of Pfizer Inc.